Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders
(NASDAQ: JAGX) Delayed: 2.61 +0.36 (16.00%)
Previous Close $2.25    52 Week High $4.60 
Open $2.28    52 Week Low $0.81 
Day High $2.77    P/E N/A 
Day Low $2.26    EPS $0.00 
Volume 274,985